H. Manganas

发表

Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease.

T. To, C. Ryerson, A. Halayko, 2021, Annals of the American Thoracic Society.

Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis

C. Ryerson, P. Hernandez, P. Laurin, 2018, European Respiratory Journal.

Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society Position Statement

C. Ryerson, M. Kolb, J. Morisset, 2020, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.

T. To, C. Ryerson, A. Halayko, 2019, Chest.

Comprehensive management of fibrotic interstitial lung diseases: A Canadian Thoracic Society position statement

C. Ryerson, M. Kolb, P. Camp, 2018, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease

C. Ryerson, M. Kolb, N. Khalil, 2022, Respirology.

Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILD.

C. Ryerson, M. Kolb, N. Khalil, 2022, Respiratory medicine.

Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease Associated Interstitial Lung Disease.

T. To, C. Ryerson, A. Halayko, 2020, Annals of the American Thoracic Society.

Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease

C. Ryerson, K. Gibson, Yingze Zhang, 2022, JAMA internal medicine.

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis

M. Strek, C. Ryerson, A. Halayko, 2022, Respirology.

Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report

A. Churg, C. Ryerson, J. Yee, 2018, BMC Pulmonary Medicine.

A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease

T. To, C. Ryerson, A. Halayko, 2020, Respiratory Research.

Transbronchial lung cryobiopsy for ILD: Ready or not, here it comes?

A. Churg, C. Ryerson, M. Kolb, 2018, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

L. Richeldi, C. Ryerson, A. Halayko, 2022, European Respiratory Journal.

High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.

F. Maltais, J. Bourbeau, N. Eves, 2016, Annals of the American Thoracic Society.

The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry

T. To, C. Ryerson, A. Halayko, 2016, Canadian respiratory journal.

Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease

A. Comtois, B. Dubé, J. Morisset, 2019, Journal of cardiopulmonary rehabilitation and prevention.

Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis

T. To, C. Ryerson, A. Halayko, 2019, BMC Pulmonary Medicine.

Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease

T. To, C. Ryerson, A. Halayko, 2021, Respiratory Research.

Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease

T. To, C. Ryerson, A. Halayko, 2020, Thorax.

Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement

J. Leipsic, A. Churg, C. Ryerson, 2017 .

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis

H. Collard, E. Vittinghoff, K. Jones, 2017, Chest.

Association of Body Mass Index and Change in Weight with Mortality in Patients with Fibrotic Interstitial Lung Disease.

H. Collard, C. Ryerson, A. Halayko, 2021, Chest.

Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease.

Y. Lacasse, F. Maltais, F. Dagenais, 2007, Canadian respiratory journal.

Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease

C. Ryerson, Wei Zhang, M. Kolb, 2023, PloS one.

Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study

C. Ryerson, A. Halayko, M. Kolb, 2022, Respiratory Medicine.

Neighborhood-level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.

C. Ryerson, K. Gibson, Yingze Zhang, 2021, American journal of respiratory and critical care medicine.

Trajectories and prognostic significance of 6-minute walk test parameters in fibrotic interstitial lung disease: A multi-center study.

C. Ryerson, A. Halayko, M. Kolb, 2022, Chest.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort

C. Ryerson, M. Kolb, N. Khalil, 2023, Journal of thoracic disease.

Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease

A. Comtois, B. Dubé, J. Morisset, 2019, Journal of cardiopulmonary rehabilitation and prevention.

Characteristics of pulse oximetry and arterial blood gas in patients with fibrotic interstitial lung disease

J. Morisset, D. Assayag, J. Fisher, 2024, BMJ open respiratory research.